Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A

Disclosed is a substantially pure isostructural pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a- homoerythromycin A having the Formula (I), wherein: S is an organic solvent which is at least partially miscible with water and y is 0, and x is 1. Wherein the pseudopolymorph is characterized by the mono...

Full description

Saved in:
Bibliographic Details
Main Authors DANILOVSKI, ALEKSANDAR, CINCIC, DOMINIC, DUMIC, MILJENKO, ORESIC, MARINA, BUCAR, DEJAN-KRESIMIR, MESTROVIC, ERNEST, FILIC, DARKO, LAZARIC, KATICA, LAZAREVSKI, GORJANA, VINKOVIC, MLADEN, DUMBOVIC, ALOJZ, KNEZEVIC, ZDRAVKA
Format Patent
LanguageEnglish
Published 30.11.2006
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed is a substantially pure isostructural pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a- homoerythromycin A having the Formula (I), wherein: S is an organic solvent which is at least partially miscible with water and y is 0, and x is 1. Wherein the pseudopolymorph is characterized by the monoclinic space group P2 and average unit cell parameters comprising: Crystal axis lengths of: a = 15.5-17.O angstroms, b = 15.5-17.O angstroms and c = 17.5-19.5 angstroms; and Angles between the crystal axes of alpha = gamma = 90 degrees and beta = 106 degrees-112 degrees. The monohydrate forms of azithromycin claimed are useful for the treatment of bacterial and protozoan infections and inflammation-related diseases.
Bibliography:Application Number: NZ20030535477